Glyciphage P 15 mg/500 mg Tablet SR
Glyciphage P 15 mg/500 mg Tablet SR
Pioglitazone (15mg) + Metformin (500mg)
K-Pio-M Tablet ER
Blue Cross Laboratories Ltd
Pioglitazone 15mg
Pack Size
1 units
Price
Save ₹39
that's 49% off!
About This Medicine
Product description & overview
Glyciphage P: A Combined Therapy for Improved Blood Sugar Control
Glyciphage P is a sustained-release tablet containing a combination of Pioglitazone (15mg) and Metformin (500mg). This dual-action formula is designed to effectively manage Type 2 diabetes by targeting both insulin sensitivity and blood glucose levels.
Pioglitazone: A thiazolidinedione medication that acts as an agonist for peroxisome proliferator-activated receptor gamma (PPARγ), increasing insulin sensitivity in muscle cells, improving glucose uptake and reducing insulin resistance.
Metformin: A first-line therapy for type 2 diabetes, metformin lowers hepatic glucose production, inhibits intestinal glucose absorption, and enhances insulin sensitivity.
Glyciphage P tablets offer a convenient once-daily dosage solution, ensuring consistent blood sugar control throughout the day. It is vital to consult your healthcare provider before starting or altering any medication regimen.
Note: This description is for informational purposes only and should not be considered medical advice. Always follow your doctor's instructions when taking medications.
Active composition
Pioglitazone 15 mg
+1 more active ingredient
About Pioglitazone
Pioglitazone is an antidiabetic medication used to treat type 2 diabetes. It works by improving insulin sensitivity and regulating blood sugar levels. Pioglitazone is effective in managing diabetes. In summary, Pioglitazone is beneficial for treating type 2 diabetes.
How It Works
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Glyciphage P 15 mg/500 mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Glyciphage P 15 mg/500 mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Glyciphage P 15 mg/500 mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glyciphage P 15 mg/500 mg Tablet SR may be needed. Please consult your doctor. Use of Glyciphage P 15 mg/500 mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Glyciphage P 15 mg/500 mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glyciphage P 15 mg/500 mg Tablet SR may be needed. Please consult your doctor. Glyciphage P 15 mg/500 mg Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Glyciphage P 15 mg/500 mg Tablet SR